Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioRestorative Therapies, Inc.

1.77
+0.15009.26%
Post-market: 1.71-0.0600-3.39%18:27 EDT
Volume:57.96K
Turnover:99.11K
Market Cap:12.25M
PE:-1.27
High:1.78
Open:1.64
Low:1.62
Close:1.62
Loading ...

Analysts Are Bullish on Top Healthcare Stocks: BioRestorative Therapies (BRTX), Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
02 Mar

BioRestorative Therapies Says FDA Clears BRTX-100 Trial in Chronic Cervical Discogenic Pain

MT Newswires Live
·
27 Feb

BioRestorative announces FDA clearance of IND for Phase 2 BRTX-100 trial

TIPRANKS
·
27 Feb

BioRestorative Announces FDA Clearance of Ind for Phase 2 Trial of Brtx-100 in Chronic Cervical Discogenic Pain

THOMSON REUTERS
·
27 Feb

BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain

GlobeNewswire
·
27 Feb

BioRestorative Announces Updated Time for February 27TH Webcasted Conference Call to Discuss Clinical Pipeline Update

THOMSON REUTERS
·
27 Feb

BioRestorative Announces Updated Time for February 27th Webcasted Conference Call to Discuss Clinical Pipeline Update

GlobeNewswire
·
27 Feb

BioRestorative to Provide a Positive FDA Update on Clinical Pipeline

THOMSON REUTERS
·
25 Feb

BioRestorative to Provide a Positive FDA Update on Clinical Pipeline

GlobeNewswire
·
25 Feb

BioRestorative Therapies announces new data on BRTX-100 presented at ORS 2025

TIPRANKS
·
10 Feb

BRTX-100 Front and Center at ORS 2025

GlobeNewswire
·
10 Feb

BioRestorative Therapies, Inc.'s (NASDAQ:BRTX) Shift From Loss To Profit

Simply Wall St.
·
05 Feb

BRIEF-Biorestorative Therapies Inc - Patent Protection Expected Until April 2040

Reuters
·
05 Dec 2024

BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting Thermostem® Metabolic Disease Program

THOMSON REUTERS
·
05 Dec 2024

BioRestorative Therapies Inc - Patent Protection Expected Until April 29, 2040

THOMSON REUTERS
·
05 Dec 2024

BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting ThermoStem® Metabolic Disease Program

GlobeNewswire
·
05 Dec 2024